Cicala, G.; Barbieri, M.A.; Russo, G.; Salvo, F.; Spina, E.
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals 2024, 17, 342.
https://doi.org/10.3390/ph17030342
AMA Style
Cicala G, Barbieri MA, Russo G, Salvo F, Spina E.
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals. 2024; 17(3):342.
https://doi.org/10.3390/ph17030342
Chicago/Turabian Style
Cicala, Giuseppe, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, and Edoardo Spina.
2024. "Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data" Pharmaceuticals 17, no. 3: 342.
https://doi.org/10.3390/ph17030342
APA Style
Cicala, G., Barbieri, M. A., Russo, G., Salvo, F., & Spina, E.
(2024). Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals, 17(3), 342.
https://doi.org/10.3390/ph17030342